Exploratory investigation of urinary alkanes and other volatile organic compounds in paediatric patients with tuberculous meningitis
- PMID: 40789978
- PMCID: PMC12339628
- DOI: 10.1007/s11306-025-02304-5
Exploratory investigation of urinary alkanes and other volatile organic compounds in paediatric patients with tuberculous meningitis
Abstract
Background: Tuberculous meningitis (TBM) is a disease caused by Mycobacterium tuberculosis (M. tb) infection of the brain. Alkanes and other volatile organic compounds (VOCs) are biologically important metabolites that are used by infectious mycobacteria species for growth and survival strategies.
Objective: This study investigated the altered alkanes and other VOCs in the urine from paediatric cases with TBM.
Method: We used untargeted gas chromatography coupled with time-of-flight mass spectrometry (GC-TOFMS) to analyse and compare all volatile, underivatised compounds present in the urine from 27 confirmed cases of paediatric TBM over a treatment period of six months, as well as a control group (n = 13).
Result: Four elevated alkanes (pentadecane, 5,7-dimethyl-undecane, 4,7-dimethyl-undecane, and 2,6-dimethyl-undecane), three alkenes (decreased 2,5-dimethyl-2-hexene and 4,4-dimethyl-1-pentene, and increased 3-methoxy-1-pentene), and three other VOCs of biological interest (decreased 2-butenoic acid methyl ester and 3-heptanone, and increased 2-pyrrolidinone) were identified as statistically significant. These volatile compounds remained perturbed during the TBM treatment.
Conclusion: This study discovered new systemic metabolic information about M. tb in the host and the role of alkanes and VOCs in the potential persistence of M. tb. We demonstrate the value of targeting alkanes and other VOCs for future metabolomics studies of M. tb.
Keywords: Alkanes; Gas chromatography coupled with time-of-flight mass spectrometry (GC-TOFMS); Metabolomics; Paediatric; Tuberculous meningitis (TBM); Urine; Volatile organic compounds (VOCs).
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Figures



References
-
- Banday, K. M., Pasikanti, K. K., Chan, E. C. Y., Singla, R., Rao, K. V. S., Chauhan, V. S., & Nanda, R. K. (2011). Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects. Analytical Chemistry, 83(14), 5526–5534. - PubMed
-
- Bourre, J. M., Cassagne, C., Larrouquere-Regnier, S., & Darriet, D. (1977). Occurrence of alkanes in brain myelin. Comparison between normal and quaking mouse. Journal of Neurochemistry, 29(4), 645–648. - PubMed
-
- Broza, Y. Y., Har-Shai, L., Jeries, R., Cancilla, J. C., Glass-Marmor, L., Lejbkowicz, I., Torrecilla, J. S., Yao, X., Feng, X., Narita, A., & Müllen, K. (2017). Exhaled breath markers for nonimaging and noninvasive measures for detection of multiple sclerosis. ACS Chemical Neuroscience, 8(11), 2402–2413. - PubMed
-
- Callery, P. S., Geelhaar, L. A., & Stogniew, M. (1978). 2-PyrroIidinone—A cyclization product of γ-aminobutyric acid detected in mouse brain. Biochemical Pharmacology, 27, 2061–2063. - PubMed
-
- Cheepsattayakorn, A., & Cheepsattayakorn, R. (2014). Breath tests in diagnosis of pulmonary tuberculosis. Recent Patents on Biotechnology, 8, 172–175. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous